Monitoring Response to TKI Therapy, Mutational Analysis, and New Treatment Options in CML

Learning Objectives

At the conclusion of this session, the participant should be able to:

  • Integrate into professional practice the key updates of the NCCN Guidelines related to CML
Course summary
Available credit: 
  • 1.00 Case Manager
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
  • 1.00 Tumor Registrar
Course opens: 
03/16/2013
Course expires: 
04/18/2014
Cost:
$0.00
Part of: 
NCCN 18th Annual Conference: Advancing the Standard of Cancer Care™

Jerald P. Radich, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Available Credit

  • 1.00 Case Manager
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
  • 1.00 Tumor Registrar

Price

Cost:
$0.00
Please login or register to take this course.